GGrantIndex
← Leaderboards

Daniela M Dinulescu

Massachusetts Institute Of Technology

$2,065,033
Attributed
$5,698,641
Total exposure
4
Grants
1
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.1M · FY200522
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22

Funding mix

By agency

NIH$5,698,641 · 4

By mechanism

U01$3,531,325 · 1
R01$1,970,228 · 1
R03$170,342 · 1
F32$26,746 · 1

Top collaborators

Most similar at Massachusetts Institute Of Technology

Same institution · by research overlap

Others in their field

Top investigators on “Cancer Patient

Research focus

Cancer PatientMolecularCancer CellMalignant Neoplasm Of OvaryLeadCellsSerousMalignant NeoplasmsDesignBaseOperative Surgical ProceduresInnovationProteinsNanotechnologyMembraneNanoscaleCell Culture TechniquesMouse ModelMalignant Female Reproductive System NeoplasmOvarianOvaryMammalian OviductsIn VitroDiagnostic

Grant awards (15)

Early Detection through Novel OCEAN Technology - Ovarian Cancer Exosomal Analysis with Nanoplasmonics$573,531
U01 · FY2022 · CA
Subcellular enzyme-instructed self-assembly for molecular anticancer nanomedicines$73,705
R01 · FY2022 · CA
Early Detection through Novel OCEAN Technology - Ovarian Cancer Exosomal Analysis with Nanoplasmonics$746,693
U01 · FY2021 · CA
Subcellular Enzyme-instructed self-assembly for molecular anticancer nanomedicines$51,237
R01 · FY2021 · CA
Early Detection through Novel OCEAN Technology - Ovarian Cancer Exosomal Analysis with Nanoplasmonics$746,693
U01 · FY2020 · CA
Early Detection through Novel OCEAN Technology - Ovarian Cancer Exosomal Analysis with Nanoplasmonics$705,145
U01 · FY2019 · CA
Enzyme-instructed self-assembly for molecular anticancer nanomedicines$357,100
R01 · FY2019 · CA
Early Detection through Novel OCEAN Technology - Ovarian Cancer Exosomal Analysis with Nanoplasmonics$759,263
U01 · FY2018 · CA
Enzyme-instructed self-assembly for molecular anticancer nanomedicines$368,145
R01 · FY2018 · CA
Enzyme-instructed self-assembly for molecular anticancer nanomedicines$368,145
R01 · FY2017 · CA
Enzyme-instructed self-assembly for molecular anticancer nanomedicines$368,145
R01 · FY2016 · CA
Enzyme-instructed self-assembly for molecular anticancer nanomedicines$383,751
R01 · FY2015 · CA
Defining microRNA Signatures for Early Detection in BRCA-Mutated Ovarian Cancer$85,285
R03 · FY2015 · CA · contact PI
Defining microRNA Signatures for Early Detection in BRCA-Mutated Ovarian Cancer$85,057
R03 · FY2014 · CA · contact PI
Mouse Models of Endometriosis and Ovarian Cancer$26,746
F32 · FY2005 · CA